Cardinal Health, Inc. (NYSE:CAH) Files An 8-K Results of Operations and Financial Condition

Cardinal Health, Inc. (NYSE:CAH) Files An 8-K Results of Operations and Financial Condition
Item 2.02

On July 16, 2019, Cardinal Health, Inc. (the “Company”) issued a news release that, among other things, affirmed that the Company expects to meet at least the midpoint of its non-GAAP earnings per share guidance range for the fiscal year ended June 30, 2019, which was reported in its May 9, 2019 earnings release. A copy of the news release is furnished with this report as Exhibit 99.1.
Jon L. Giacomin, Chief Executive Officer—Medical Segment, has notified the Company that he will leave the Company effective August 16, 2019.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
CARDINAL HEALTH INC Exhibit
EX-99.1 2 exhibit991news_release32.htm EXHIBIT 99.1 Exhibit Exhibit 99.1FOR IMMEDIATE RELEASE     Media:Brandi Martin Investors: Lisa Capodici (614) 757-3383  (614) 757-5035 [email protected]  [email protected] HEALTH APPOINTS STEPHEN MASON TO LEAD MEDICAL SEGMENTCompany Expects to Meet at Least the Midpoint of its Previously Announced Non-GAAP EPS Guidance for Fiscal Year ’19DUBLIN,…
To view the full exhibit click here

Story continues below

About Cardinal Health, Inc. (NYSE:CAH)

Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.

An ad to help with our costs